journal article·2023-07-03

Two-in-One Visual Gelatin Embolization Microspheres for Precise Localization and Rapid Embolization Studies

Fengyuan Gao, Tingting Han, Muhammad Rafiq, Luping Chen, Song Wang, Jian Li, Hailin Cong, Bing Yu, Youqing Shen

ACS Materials Letters· Volume 5· Issue 7
Publisher page

Abstract

Transcatheter arterial embolization (TAE) has played a huge role in interventional therapy and tumor embolization of organ hemorrhage and accidental hemorrhage. The selection of embolic materials with better biocompatibility is an important part of TAE. In this work, we prepared a gelatin microspheres (GMs) embolization material that simultaneously encapsulates silver sulfide quantum dots (Ag 2 S QDs) and barium sulfate (BaSO 4 ), giving it good near-infrared second region (NIR-II) imaging and X-ray imaging effects, while luminescence effect of NIR-II is better than that of X-ray, which breaks the limitation of traditional embolization microspheres with only X-ray imaging. In order to improve the therapeutic effect on tumors, we loaded doxorubicin (DOX) antitumor drugs inside the microspheres and bound thrombin on the surface of the microspheres. Thereby, not only can it help achieve rapid embolization during hemostasis, but its sustained release can also accelerate tumor necrosis. The microspheres have good biocompatibility and blood compatibility. Preliminary application results show that the microspheres can achieve a good embolization effect in the ear artery and renal artery of New Zealand white rabbits. Thus, they can be used as a potential embolization system for drug delivery as well as an effective material for arterial embolization and hemostasis. Significantly, this work realizes the clinical embolization application of NIR-II combined with X-ray multimodal imaging technology in biomedical imaging.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Lanthanide and Transition Metal Complexes · Intracranial Aneurysms: Treatment and Complications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, China

State Key Laboratory of Bio-Fibers and Eco-Textiles, Qingdao University, Qingdao 266071, China

School of Materials Science and Engineering, Shandong University of Technology, Zibo 255000, China

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Center for Bionanoengineering, and Department of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China

Funding

Qingdao Municipal Science and Technology Bureau · State Key Laboratory of Bio-Fibers and Eco-Textiles · National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · High Level Discipline Project of Shandong Province

References (45)

Show source-provided references
1. 10.1016/j.jimed.2019.09.00510.1016/j.jimed.2019.09.005 ↗
2. 10.1002/adhm.20160129110.1002/adhm.201601291 ↗
3. 10.1016/j.jconrel.2016.02.03310.1016/j.jconrel.2016.02.033 ↗
4. 10.1016/j.actbio.2019.02.03510.1016/j.actbio.2019.02.035 ↗
5. 10.1021/acs.biomac.5b0002710.1021/acs.biomac.5b00027 ↗
6. 10.1016/j.carbpol.2018.07.06510.1016/j.carbpol.2018.07.065 ↗
7. 10.1016/j.biomaterials.2016.06.06410.1016/j.biomaterials.2016.06.064 ↗
8. 10.1039/D0TB02499F10.1039/D0TB02499F ↗
9. 10.1039/D2BM00283C10.1039/D2BM00283C ↗
10. 10.1002/advs.20200044110.1002/advs.202000441 ↗
11. 10.1039/D0TB02120B10.1039/D0TB02120B ↗
12. 10.1002/adma.20180239410.1002/adma.201802394 ↗
13. 10.1021/acsapm.0c0063710.1021/acsapm.0c00637 ↗
14. 10.1039/C8SC03751E10.1039/C8SC03751E ↗
15. 10.1002/adma.20190032110.1002/adma.201900321 ↗
16. 10.1002/smll.20210325210.1002/smll.202103252 ↗
17. 10.1016/j.cclet.2020.04.03010.1016/j.cclet.2020.04.030 ↗
18. 10.1373/clinchem.2015.24862510.1373/clinchem.2015.248625 ↗
19. 10.1002/adma.20200261110.1002/adma.202002611 ↗
20. 10.1016/j.actbio.2021.07.00610.1016/j.actbio.2021.07.006 ↗
21. 10.1016/j.biomaterials.2020.12040810.1016/j.biomaterials.2020.120408 ↗
22. 10.1016/j.foodchem.2019.12564210.1016/j.foodchem.2019.125642 ↗
23. 10.1136/neurintsurg-2021-01730810.1136/neurintsurg-2021-017308 ↗
24. 10.1016/j.colsurfb.2019.11076110.1016/j.colsurfb.2019.110761 ↗
25. 10.1016/j.aca.2014.04.05510.1016/j.aca.2014.04.055 ↗
26. 10.1161/ATVBAHA.114.30411410.1161/ATVBAHA.114.304114 ↗
27. 10.1111/jth.1501610.1111/jth.15016 ↗
28. 10.1016/j.pharmthera.2020.10764910.1016/j.pharmthera.2020.107649 ↗
29. 10.1089/ten.teb.2019.025610.1089/ten.teb.2019.0256 ↗
30. 10.1016/j.foodhyd.2020.10631410.1016/j.foodhyd.2020.106314 ↗
31. 10.1021/ja909490r10.1021/ja909490r ↗
32. 10.1016/j.ijbiomac.2020.05.18910.1016/j.ijbiomac.2020.05.189 ↗
33. 10.1021/bm500091e10.1021/bm500091e ↗
34. 10.1039/D1QM00489A10.1039/D1QM00489A ↗
35. 10.1016/j.ijbiomac.2017.07.08210.1016/j.ijbiomac.2017.07.082 ↗
36. 10.1001/jama.2014.719210.1001/jama.2014.7192 ↗
37. 10.1021/acs.biomac.8b0073410.1021/acs.biomac.8b00734 ↗
38. 10.7150/thno.2737910.7150/thno.27379 ↗
39. 10.1016/j.actbio.2021.05.03110.1016/j.actbio.2021.05.031 ↗
40. 10.1016/j.colsurfb.2019.11072010.1016/j.colsurfb.2019.110720 ↗
41. 10.1016/j.ijbiomac.2020.04.03710.1016/j.ijbiomac.2020.04.037 ↗
42. 10.1021/acsami.6b1069710.1021/acsami.6b10697 ↗
43. 10.1016/j.colsurfb.2015.05.03710.1016/j.colsurfb.2015.05.037 ↗
44. 10.1098/rstb.2013.009910.1098/rstb.2013.0099 ↗
45. 10.1039/C8TB00542G10.1039/C8TB00542G ↗